The future of crossborder healthcare

What are the biggest trends currently shaping the international healthcare and medical assistance sector, and how is Medipol adapting to them?

The sector is increasingly focused on coordination, accessibility and the overall patient experience. Patients today are more informed than ever and expect not only high clinical standards, but also responsive communication, transparency, and seamless support throughout every stage of their healthcare journey.

We are also seeing stronger collaboration between hospitals, insurers, assistance companies and other international healthcare stakeholders. Technology is accelerating this transformation by making information sharing, remote communication and coordination more efficient.

At Medipol, we are strengthening our capabilities in international healthcare coordination and focusing not only on the clinical process, but on the patient’s entire healthcare journey. Our approach brings together clinical expertise and strong healthcare infrastructure with multilingual communication, dedicated international patient services and close collaboration with our global partners.

How has the profile and expectations of international patients changed in recent years?

The pandemic changed the way patients approach healthcare. Remote consultations became a familiar part of care, and awareness of infection control and patient safety increased.

Today, international patients conduct more research before travelling for treatment and are more conscious of quality, safety, waiting times and continuity of care. Rather than viewing healthcare as a series of separate services, patients increasingly expect a coordinated and integrated healthcare experience.

Patients are becoming more involved in decisions about their own treatment. They want clear and understandable information about their diagnosis, treatment options, expected outcomes and costs.

Trust has become even more important too. International patients and their families want to feel confident that their healthcare provider can manage not only the medical process, but also communication, logistics and follow-up after treatment. This has further increased the importance of dedicated international patient services and strong partnerships with assistance and insurance companies.

What role does technology play in improving patient outcomes and streamlining care coordination across borders?

Technology has become a key enabler of cross-border healthcare. Its role extends beyond medical technologies; it also supports communication, information sharing and coordination between stakeholders.

Digital systems can enable healthcare providers to access relevant clinical information more quickly, communicate with patients before and after treatment, and coordinate more effectively with insurers and assistance companies. Telemedicine and remote consultations can also provide significant benefits, particularly when a patient needs specialist advice before travelling or requires follow-up after returning to their home country.

Access to imaging and clinical reports before arrival allows patients to be directed to the right specialist more quickly, while structured follow-up after discharge helps identify potential complications early.

At the same time, technology should not replace the human element of healthcare; it should support it. International patients often need trust and guidance alongside clinical expertise. At Medipol, we see technology as a tool that enables our teams and partners to work more effectively, while keeping the patient at the centre of the process.

Medical assistance cases often involve multiple stakeholders. What are the key factors in ensuring smooth collaboration between hospitals, insurers, assistance companies, and patients?

Clear communication and well-defined responsibilities are among the most important factors. In a medical assistance case, even a relatively minor delay in communication can affect the patient’s healthcare journey, particularly when treatment, travel, accommodation or repatriation arrangements are involved.

From our perspective, three elements are essential: accurate medical information, timely communication and a shared understanding of the patient’s needs among all stakeholders.

Hospitals need to provide reliable clinical information, while assistance companies and insurers need to communicate coverage and operational requirements clearly. Patients and their families also play an active role: sharing their complete medical history and keeping all parties informed of their preferences helps avoid unnecessary delays.

It is also important to have experienced teams who understand the expectations and working processes of international partners. At Medipol, within our international patient services, our International Contracted Institutions Department manages the processes relating to our contracted insurers and assistance partners. Our teams work closely with clinical departments and external stakeholders, contributing to the coordination of the patient journey from admission through treatment and discharge.

Our fundamental aim is to create a process that is predictable and transparent for all parties involved.

Can you share some of the challenges healthcare providers face when treating international patients, and how Medipol addresses them?

International healthcare brings a range of challenges beyond clinical care. Language and cultural differences, different healthcare systems, documentation requirements, insurance procedures and communication expectations can all directly affect the patient experience.

Another key consideration is ensuring that information is communicated consistently to the patient, their family and external stakeholders.This becomes particularly important in complex cases involving multiple specialties or longerterm treatment pathways.

At Medipol, our approach is built around coordination and dedicated international patient services. Multilingual communication, experienced international patient teams and close collaboration between clinical and operational units help us manage different requirements effectively.

We also aim to clarify processes and expectations with our international partners as early as possible. For us, the key is to anticipate potential challenges before they become operational issues.

As demand for cross-border healthcare grows, what steps are needed to maintain high clinical standards while ensuring accessibility and efficiency?

Growth in cross-border healthcare must always be accompanied by a strong focus on clinical quality and patient safety. Accessibility and efficiency should not come at the expense of clinical standards; rather, they should be achieved through better organisation and coordination.

At Medipol, we maintain communication with our patients not only while they are in Türkiye, but also after they return to their home countries

Healthcare providers need strong clinical governance systems, qualified multidisciplinary teams, transparent processes and appropriate healthcare infrastructure. At the same time, it is important to develop efficient service models that reduce unnecessary waiting times and administrative complexity for international patients.

At Medipol, this approach is supported by established quality and accreditation frameworks.

Medipol Mega University Hospital holds JCI Academic Medical Center Hospital accreditation, reflecting its commitment to internationally recognised standards in clinical quality, patient safety and healthcare management. This framework supports our efforts to maintain consistent standards while continuously improving our clinical and operational processes.

Another priority area is measuring the patient experience and treatment outcomes.

International healthcare providers need to regularly assess where delays or communication issues occur within their processes and make improvements accordingly.

We believe that sustainable growth depends on developing systems capable of meeting increasing international patient demand without compromising the quality and safety of care.

What measures does Medipol take to ensure continuity of care for patients who require treatment, repatriation, or follow-up in their home country?

Continuity of care should not be considered a process that ends when a patient leaves the hospital. Particularly for international patients, maintaining communication and providing the necessary medical guidance after treatment is an integral part of the overall healthcare experience.

At Medipol, we maintain communication with our patients not only while they are in Türkiye, but also after they return to their home countries. Our network of more than 20 representative offices plays a central role in maintaining communication with our patients throughout this process and, when needed, facilitating their access to healthcare services.

For patients who require repatriation, our physicians assess their medical condition and fitness to travel and prepare the necessary medical documentation to support a safe transfer. Where required, this may include fit-to-fly documentation and airline medical information forms (MEDIF). Our teams can also liaise with assistance companies, air ambulance providers and medical escorts, with physician-to-physician communication where appropriate, to help ensure that the patient’s transfer is planned and coordinated according to their medical needs.

Depending on the patient’s circumstances, medical reports, treatment plans and follow-up requirements are shared after treatment with the patient and, with their consent, their physicians at home. Where necessary, we also maintain communication between our physicians and patients through online consultations. We can also coordinate with assistance companies, insurers and healthcare providers in the patient’s home country when required.

Our aim is to ensure that the necessary follow-up, communication and medical support continue as seamlessly as possible after the patient returns home.

Looking ahead, what opportunities and challenges do you see for healthcare providers operating in an increasingly globalised medical landscape?

The globalisation of healthcare is creating significant opportunities in terms of information sharing, international collaboration and access to specialised healthcare services. Patients can now access healthcare providers beyond their home countries more easily, while hospitals can build international networks with insurers, assistance companies and other healthcare organisations.

At the same time, the sector will need to respond to increasing expectations around quality, transparency, data security, accessibility and continuity of care. I believe competition between healthcare providers will be shaped not only by clinical capabilities, but also by how effectively the entire patient healthcare journey is coordinated.

The future of international healthcare will be built on collaboration. No single organisation can manage every stage of a cross-border healthcare journey on its own. Hospitals, insurers, assistance companies and other stakeholders will need to work together within an integrated ecosystem.

Ultimately, healthcare providers that can bring together clinical excellence, effective coordination and a patient-centred approach will shape the next phase of international healthcare.